IE912466A1 - Rapid immunoselection cloning method - Google Patents

Rapid immunoselection cloning method

Info

Publication number
IE912466A1
IE912466A1 IE246691A IE246691A IE912466A1 IE 912466 A1 IE912466 A1 IE 912466A1 IE 246691 A IE246691 A IE 246691A IE 246691 A IE246691 A IE 246691A IE 912466 A1 IE912466 A1 IE 912466A1
Authority
IE
Ireland
Prior art keywords
cells
cell
cdna
antigen
dna
Prior art date
Application number
IE246691A
Other languages
English (en)
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of IE912466A1 publication Critical patent/IE912466A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
IE246691A 1990-07-13 1991-07-15 Rapid immunoselection cloning method IE912466A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US55375990A 1990-07-13 1990-07-13

Publications (1)

Publication Number Publication Date
IE912466A1 true IE912466A1 (en) 1992-01-15

Family

ID=24210641

Family Applications (1)

Application Number Title Priority Date Filing Date
IE246691A IE912466A1 (en) 1990-07-13 1991-07-15 Rapid immunoselection cloning method

Country Status (8)

Country Link
EP (1) EP0551301A1 (fr)
JP (3) JPH06504186A (fr)
KR (1) KR100206524B1 (fr)
AU (1) AU658370B2 (fr)
CA (1) CA2087272C (fr)
IE (1) IE912466A1 (fr)
PT (1) PT98326B (fr)
WO (1) WO1992001049A2 (fr)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6130202A (en) * 1990-07-20 2000-10-10 Bayer Corporation Antiviral methods
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5316920A (en) * 1992-04-17 1994-05-31 Dana-Faber Cancer Institute, Inc. Lymphocyte activation antigen HB15, a member of the immunoglobulin superfamily
WO1993022340A1 (fr) * 1992-04-30 1993-11-11 Schering Corporation Modulation des interactions entre cd36 et la thrombospondine
JP2800850B2 (ja) * 1992-07-21 1998-09-21 アイシス・イノベーション・リミテッド 新生物形成の検出方法
WO1996033217A1 (fr) * 1995-04-19 1996-10-24 Kanegafuchi Kagaku Kogyo Kabushiki Kaisha Proteine d'adhesion de cellules, agent immunosuppresseur contenant cette proteine et agent immunosuppresseur renfermant des cellules ainsi induites
US5990299A (en) * 1995-08-14 1999-11-23 Icn Pharmaceuticals, Inc. Control of CD44 gene expression for therapeutic use
WO1997020046A1 (fr) * 1995-11-30 1997-06-05 Schering Corporation Molecule d'adn, antigene tn et molecule d'adhesion appartenant a la superfamille des immunoglobulines
US5863735A (en) * 1997-02-24 1999-01-26 Incyte Pharmaceuticals, Inc. Human transmembrane 4 superfamily protein
US5854022A (en) * 1997-05-13 1998-12-29 Incyte Pharmaceuticals, Inc. Polynucleotides encoding a CD53-like transmembrane protein
US6486299B1 (en) * 1998-09-28 2002-11-26 Curagen Corporation Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity
EP1006183A1 (fr) * 1998-12-03 2000-06-07 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Récepteurs Fc recombinantes et solubles
EP1421174B1 (fr) 2000-10-18 2009-12-23 The Brigham And Women's Hospital, Inc. Polypeptides ligands de e-selectine/l-selectine et methodes d'utilisation associees
WO2005044075A2 (fr) * 2003-09-19 2005-05-19 Diadexus, Inc. Compositions, variantes d'epissures, et procedes se rapportant a des genes et proteines specifiques du sein
CN101218256B (zh) 2005-03-23 2017-04-19 根马布股份公司 用于治疗多发性骨髓瘤的cd38抗体
CA2654425C (fr) 2006-06-02 2019-09-17 Robert Sackstein Compositions et procedes pour modifier des glycans de surface cellulaire
US9040050B2 (en) 2006-09-26 2015-05-26 Genmab A/S Combination treatment of CD38-expressing tumors
EP2090320A1 (fr) * 2008-02-15 2009-08-19 Helmholtz-Zentrum für Infektionsforschung GmbH Ligands du marqueur CD27 de surface de cellule tueuse naturelle (NK) et ses utilisations thérapeutiques
EA201690310A1 (ru) 2010-04-13 2016-12-30 Селлдекс Терапьютикс Инк. Антитела, связывающие cd27 человека, и их применение
WO2011154453A1 (fr) 2010-06-09 2011-12-15 Genmab A/S Anticorps dirigés contre le cd38 humain
US9603927B2 (en) 2014-02-28 2017-03-28 Janssen Biotech, Inc. Combination therapies with anti-CD38 antibodies
US9732154B2 (en) 2014-02-28 2017-08-15 Janssen Biotech, Inc. Anti-CD38 antibodies for treatment of acute lymphoblastic leukemia
SG11201701867SA (en) 2014-09-09 2017-04-27 Janssen Biotech Inc Combination therapies with anti-cd38 antibodies
IL307913A (en) 2014-12-04 2023-12-01 Janssen Biotech Inc Anti-CD38 antibodies for the treatment of acute myeloid leukemia
DK3597663T3 (da) * 2014-12-08 2022-06-27 Us Health Kimære antigenreceptorer af anti-cd70
BR112017024877A2 (pt) 2015-05-20 2019-09-17 Janssen Biotech, Inc. anticorpo anti-cd38 e seu uso no tratamento de amiloidose de cadeia leve e outras malignidades hematológicas positivas para cd38
WO2016209921A1 (fr) 2015-06-22 2016-12-29 Janssen Biotech, Inc. Polythérapies pour malignités hématologiques avec des anticorps anti-cd38 et des inhibiteurs de la survivine
US20170044265A1 (en) 2015-06-24 2017-02-16 Janssen Biotech, Inc. Immune Modulation and Treatment of Solid Tumors with Antibodies that Specifically Bind CD38
MA43187B1 (fr) 2015-11-03 2021-02-26 Janssen Biotech Inc Formulations sous-cutanée d'anticorps anti-cd38 et leurs utilisations
US10781261B2 (en) 2015-11-03 2020-09-22 Janssen Biotech, Inc. Subcutaneous formulations of anti-CD38 antibodies and their uses
US11618787B2 (en) 2017-10-31 2023-04-04 Janssen Biotech, Inc. Methods of treating high risk multiple myeloma
MX2020010913A (es) 2018-04-17 2021-01-08 Celldex Therapeutics Inc Anticuerpos anti-cd27 y anti-pd-l1 y constructos biespecíficos.
BR112021026181A2 (pt) * 2019-06-27 2022-02-15 Verseau Therapeutics Inc Composições anti-cd53 e métodos para modular fenótipos inflamatórios de células mieloides e usos dos mesmos
KR20230161568A (ko) 2022-05-18 2023-11-28 엘지전자 주식회사 옷걸이 및 옷걸이를 구비하는 의류처리장치
KR20230161570A (ko) 2022-05-18 2023-11-28 엘지전자 주식회사 옷걸이 및 옷걸이를 구비하는 의류처리장치
KR20230161571A (ko) 2022-05-18 2023-11-28 엘지전자 주식회사 옷걸이 및 옷걸이를 구비하는 의류처리장치
KR20230161569A (ko) 2022-05-18 2023-11-28 엘지전자 주식회사 옷걸이 및 옷걸이를 구비하는 의류처리장치
KR20230161572A (ko) 2022-05-18 2023-11-28 엘지전자 주식회사 옷걸이 및 옷걸이를 구비하는 의류처리장치

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT53672A (en) * 1988-02-25 1990-11-28 Gen Hospital Corp Quick immunoselective cloning process

Also Published As

Publication number Publication date
AU658370B2 (en) 1995-04-13
PT98326A (pt) 1992-06-30
JP2001157592A (ja) 2001-06-12
AU8528691A (en) 1992-02-04
EP0551301A1 (fr) 1993-07-21
WO1992001049A3 (fr) 1993-09-30
CA2087272A1 (fr) 1992-01-14
PT98326B (pt) 1999-01-29
CA2087272C (fr) 2005-10-11
JP2003038179A (ja) 2003-02-12
JPH06504186A (ja) 1994-05-19
WO1992001049A2 (fr) 1992-01-23
KR100206524B1 (ko) 1999-07-01

Similar Documents

Publication Publication Date Title
AU658370B2 (en) CD53 cell surface antigen and use thereof
US6111093A (en) CD19 coding sequences
EP0330191A2 (fr) ADN encodant CD40
US6218525B1 (en) Nucleic acid encoding CD28
DE102016115246B3 (de) Neue t-zellrezeptoren und deren verwendung in immuntherapie
Clark et al. An abnormality of the gene that encodes neutrophil Fc receptor III in a patient with systemic lupus erythematosus.
DE69232921T2 (de) Änderung der zellularen immunität durch rezeptorchimäre
DE69131564T2 (de) Multimere Formen des menschlichen Rhinovirus-Rezeptorproteins
JPH05505112A (ja) Ａｉｄｓ、ａｒｃおよびｈｉｖ感染の予防および治療に有用な抗ｃｄ４抗体ホモログ
HU214247B (hu) Eljárás sejtközi adhéziós molekula ICAM-2 és kötőligandjai előállítására
Biancone et al. Inhibition of the CD40-CD40ligand pathway prevents murine membranous glomerulonephritis
AU642130B2 (en) DNA sequences, recombinant DNA molecules and processes for producing PI-linked lymphocyte function associated antigen-3
EP0636177A1 (fr) ISOLATION, CARACTERISATION ET UTILISATION DE LA SOUS-UNITE HUMAINE $g(b) DU RECEPTEUR DE HAUTE AFFINITE POUR L'IMMUNOGLOBULINE E
US5688690A (en) Human cytotoxic lymphocyte signal transduction surface protein (P38) and monoclonal antibodies thereto
DE69431068T2 (de) Das polypeptid eines membran-proteins mit der funktion zur unterstützung des wachstums von prä-b zellen und sein gen
Clayton et al. Differential regulation of T-cell receptor processing and surface expression affected by CD3 theta, an alternatively spliced product of the CD3 zeta/eta gene locus.
WO1991010722A2 (fr) Immunoglobuline chimerique pour recepteurs de cd4
AU627710C (en) Rapid immunoselection cloning method
Kinzer et al. Identification of Fc epsilon RIneg mast cells in mouse bone marrow cell cultures. Use of a monoclonal anti-p161 antibody.
KR100229114B1 (ko) 씨디27세포 표면 항원 및 그를 암호화하는 재조합 디엔에이
PT499555E (pt) Moleculas de adn recombinado que codifica uma cadeia do receptor do antigene de celulas t processo de preparacao anticorpos e medicamentos englobando-os
DE19530272C1 (de) Antikörper 103 B2
US7037496B2 (en) Chimeric immunoglobulin for CD4 receptors
WO1997007204A1 (fr) Anticorps 105a5 contre la glycoproteine liant l'agglutinine de l'arachide sur des surfaces cellulaires
JPH03254691A (ja) 薬剤耐性癌に対するキメラ抗体およびその製造